AMANDA RICHARDSON: Open Payments
NPI 1578953303 · FLOYD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,552 in 86 payments from 18 companies in 2025. Trend: 2023 $583 · 2024 $621 · 2025 $1,552
Food & beverage: $1,552
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 15 | $271 |
| ABBVIE INC. | 17 | $198 |
| Supernus Pharmaceuticals, Inc. | 9 | $154 |
| Janssen Pharmaceuticals, Inc | 5 | $116 |
| Amgen Inc. | 6 | $99 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| Alkermes, Inc. | 4 | $70 |
Products named: REXULTI, VRAYLAR, Qelbree, ABILIFY MAINTENA, Auvelity, OTEZLA, UZEDY, ARISTADA.
Industry payments across VA — which companies pay providers there.
